What belongs in the analysis
A practical scenario
Consider a simple scenario: management sees that unresolved high-impact vendor risks are aging even though general security ticket volume has improved.
Use the scenario to answer two concrete questions: What decision could this metric change? What business service or risk does it represent? The record becomes useful when those answers are supported by evidence and tied to a named decision owner.
Evidence worth gathering
Evidence should be proportionate to the importance of the decision. The following records commonly make the discussion more reliable:
- Metric definitions and data owners
- A clear link to a risk scenario or objective
- Thresholds approved by the appropriate owner
- Data-quality checks and known limitations
- Commentary explaining important movement
A practical review sequence
- Clarify exposure metrics: Show how much important service, data, supplier, or process exposure exists.
- Describe control-condition metrics: Indicate whether safeguards are operating as expected and where confidence is weak.
- Evaluate decision metrics: Track open acceptances, overdue treatments, exceptions, and unresolved ownership.
- Test outcome metrics: Show incidents, disruption, recovery performance, loss, or customer effect.
- Confirm trend and threshold: Explain movement over time and the point at which escalation or action is required.
- Close the review by answering: Can the underlying data be trusted?
Common failure modes
- Rewarding volume of activity instead of risk reduction
- Presenting a single month without trend or target
- Using red/amber/green labels without definitions
- Allowing easy-to-measure items to crowd out material exposures
Questions for management
- What decision could this metric change?
- What business service or risk does it represent?
- What threshold triggers action?
- Can the underlying data be trusted?
Frequently asked questions
What should be documented first for cyber risk metrics?
Start with exposure metrics: Show how much important service, data, supplier, or process exposure exists.
Which evidence should receive early attention?
Begin with metric definitions and data owners and a clear link to a risk scenario or objective. The right evidence is the evidence capable of changing confidence or the treatment decision.
What commonly weakens this analysis?
One frequent problem is rewarding volume of activity instead of risk reduction. The review should make that weakness visible instead of hiding it behind a score or dashboard.
When should it be revisited?
Review it on the scheduled date and whenever the conditions behind this question change: What decision could this metric change?